Brawn Biotech Ltd. Appoints Secretarial Auditor and Internal Auditors
Brawn Biotech Ltd. announced on March 25, 2026, that its Board of Directors approved the appointments of Mr. Viney and M/s Sahil Pasricha & Associates. The decisions were made at a board meeting held on March 25, 2026, which commenced at 11:00 A.M. and concluded at 11:30 A.M.Mr. Viney, a Practicing Company Secretary (CoP No. 28263), has been appointed as the Secretarial Auditor for the financial year 2025-26. He is an Associate Member of the Institute of Company Secretaries of India (ICSI) and possesses expertise in corporate, securities, and compliance management.
M/s Sahil Pasricha & Associates (FRN: 026379N), a Chartered Accountant firm, has been appointed as the Internal Auditors for the financial year 2025-26. The firm offers a range of services, including audit, taxation, and consultancy.
Annexure A: Details of Secretarial Auditor Appointment
| Details of events | Particulars |
|---|---|
| Reason for change | Appointment of Mr. Viney as the Secretarial Auditor of the Company. |
| Date of appointment & term | March 25, 2026 (Tenure - For FY 2025-26) |
| Brief Profile | Mr. Viney is a Practicing Company Secretary with expertise in corporate laws, securities laws, and compliance management, including LODR, PIT Regulations, and corporate governance advisory. |
| Disclosure of relationships between directors | Not Applicable |
Annexure B: Details of Internal Auditors Appointment
| Details of events | Particulars |
|---|---|
| Reason for change | Appointment of M/s Sahil Pasricha & Associates as Internal Auditors of the Company. |
| Date of appointment & term | March 25, 2026 (Tenure - For FY 2025-26) |
| Brief Profile | M/s Sahil Pasricha & Associates is a Chartered Accountant firm offering services including audit, income tax, GST audit, and consultancy. |
| Disclosure of relationships between directors | Not Applicable |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.